References
1. Lanas, A., et al., Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe. Aliment Pharmacol Ther, 2011. 33(11): p. 1225-33.
2. Chiu, P.W. and J.J. Sung, Acute nonvariceal upper gastrointestinal bleeding. Curr Opin Gastroenterol, 2010. 26(5): p. 425-8.
3. Fonseca, J., et al., Nonvariceal upper gastrointestinal bleeding in Portugal: a multicentric retrospective study in twelve Portuguese hospitals. Gastroenterol Hepatol, 2012. 35(6): p. 377-85.
4. Sung, J.J., et al., Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol, 2010. 105(1): p. 84-9.
5. Ferreira, R.C.N., R.C.; Rodrigues, V. et al, Portugal Doenças Cérebro-Cardiovasculares em números – 2013. Direção Geral da Saúde, 2013.
6. Barada, K., et al., Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy. J Clin Gastroenterol, 2009. 43(1): p. 5-12.
7. Garcia Rodriguez, L.A., et al., Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation, 2011. 123(10): p. 1108-15.
8. Vallurupalli, N.G. and S.Z. Goldhaber, Gastrointestinal complications of dual antiplatelet therapy. Circulation, 2006. 113(12): p. e655-8.
9. Lanas, A., et al., Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol, 2007. 102(3): p. 507-15.
10. Lanas, A., et al., Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol, 2011. 9(9): p. 762-768.e6.
11. Jorgensen, P.W., et al., Antiagregation and anticoagulation, relationship with upper gastrointestinal bleeding. Rev Esp Enferm Dig, 2011. 103(7): p. 360-5.
12. Bhatt, D.L., et al., ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation, 2008. 118(18): p. 1894-909.
13. Ducrocq, G., et al., Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J, 2010. 31(10): p. 1257-65.
14. Al Dhahab, H., et al., State-of-the-art management of acute bleeding peptic ulcer disease. Saudi J Gastroenterol, 2013. 19(5): p. 195-204.
15. Solakoglu, T., et al., Impact of anti-aggregant, anti-coagulant and non-steroidal anti-inflammatory drugs on hospital outcomes in patients with peptic ulcer bleeding. Saudi J Gastroenterol, 2014. 20(2): p. 113-9.
16. Leontiadis, G.I., V.K. Sharma, and C.W. Howden, Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev, 2006(1): p. Cd002094.
17. Khuroo, M.S., et al., Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J Gastroenterol Hepatol, 2005. 20(1): p. 11-25.
18. Barkun, A.N., et al., International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med, 2010. 152(2): p. 101-13.
19. Lu, Y., et al., Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding. Br J Surg, 2014. 101(1): p. e34-50.
20. Gralnek, I.M., et al., Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 2015. 47(10): p. a1-46.
21. Bardou, M., et al., Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther, 2005. 21(6): p. 677-86.
22. Greenspoon, J. and A. Barkun, A summary of recent recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Pol Arch Med Wewn, 2010. 120(9): p. 341-6.
23. Couto, G., G. Macedo, and F. Ribeiro, Hemorragia digestiva alta associada ao consumo de ácido acetilsalicílico e de anti-inflamatórios não-esteróides em Portugal Resultados do estudo PARAINES. Jornal Português de Gastrenterologia, 2010. 17: p. 200-206.
24. Rotondano, G., et al., Predictors of favourable outcome in non-variceal upper gastrointestinal bleeding: implications for early discharge? Dig Liver Dis, 2014. 46(3): p. 231-6.
25. Holster, I.L. and E.J. Kuipers, Management of acute nonvariceal upper gastrointestinal bleeding: current policies and future perspectives. World J Gastroenterol, 2012. 18(11): p. 1202-7.
26. Jairath, V., et al., Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Endoscopy, 2012. 44(8): p. 723-30.
27. Botianu, A., et al., Mortality and need of surgical treatment in acute upper gastrointestinal bleeding: a one year study in a tertiary center with a 24 hours / day-7 days / week endoscopy call. Has anything changed? Chirurgia (Bucur), 2013. 108(3): p. 312-8.
28. Almadi, M.A., A. Barkun, and J. Brophy, Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease. Jama, 2011. 306(21): p. 2367-74.
29. Sung, J.J., et al., Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med, 2010. 152(1): p. 1-9.
30. Derogar, M., et al., Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Clin Gastroenterol Hepatol, 2013. 11(1): p. 38-42.
31. Witt, D.M., et al., Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med, 2012. 172(19): p. 1484-91.
32. Anglin, R., et al., Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis. Am J Gastroenterol, 2014.
33. Dalton, S.O., et al., Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med, 2003. 163(1): p. 59-64.